Lataa...

Once-daily fluticasone furoate 50 mcg in mild-to-moderate asthma: a 24-week placebo-controlled randomized trial

BACKGROUND: Inhaled glucocorticosteroids (ICS) are the mainstay of treatment in asthma. Fluticasone furoate (FF) is a novel, once-daily ICS asthma therapy. This study investigated the efficacy and safety of FF 50 mcg in patients with mild-to-moderate persistent asthma. METHODS: A 24-week, multicente...

Täydet tiedot

Tallennettuna:

Bibliografiset tiedot
Julkaisussa:	Allergy
Päätekijät:	Busse, W W, Bateman, E D, O'Byrne, P M, Lötvall, J, Woodcock, A, Medley, H, Forth, R, Jacques, L
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	BlackWell Publishing Ltd 2014
Aiheet:	Original Articles
Linkit:	https://ncbi.nlm.nih.gov/pmc/articles/PMC4329337/ https://ncbi.nlm.nih.gov/pubmed/25040613 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/all.12480
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!

Once-daily fluticasone furoate 50 mcg in mild-to-moderate asthma: a 24-week placebo-controlled randomized trial

Samankaltaisia teoksia